Peter C. Farrell - 01 Apr 2026 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Director
Issuer ticker: RMD
Reported as of: 01 Apr 2026
Net transaction value: -$450,000
SEC form: 4
Accepted by SEC: 02 Apr 2026, 13:52:28 UTC
Prior SEC filing: 05 Mar 2026
Next SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Peter C. Farrell, Chairman emeritus

Key filing fact

Peter C. Farrell filed Form 4 for RESMED INC (RMD) on 02 Apr 2026.

Key facts

This page summarizes Peter C. Farrell's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 13:52.

Change

Previous filing in this sequence was filed on 05 Mar 2026.
Current net transaction value: -$450,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001186102 Primary reporting owner

FARRELL PETER C

Relationship: Director
Address: 9001 SPECTRUM CENTER BLVD., SAN DIEGO
Signature: /s/ Peter C. Farrell, Chairman emeritus
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Sale

Transaction value: $450,000
Shares: -2,000
Change %: -3.2%
Price: $225.00
Shares after: 60,773
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.